Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Chemical Reagents >Organic reagents >Hydroxylamine >Suberohydroxamic acid

Suberohydroxamic acid

Suberohydroxamic acid Structure
  • ₹5130 - ₹15469.99
  • Product name: Suberohydroxamic acid
  • CAS: 38937-66-5
  • MF: C8H16N2O4
  • MW: 204.22
  • EINECS:
  • MDL Number:MFCD00192455
  • Synonyms:ODHA;OCTANE-1,8-DIHYDROXAMIC ACID;SBHA;SUBERIC BISHYDROXAMATE;SUBEROHYDROXAMIC ACID;SUBEROYL BISHYDROXAMIC ACID;STAT3 (PTYR705);[PTYR705]-STAT3
2 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 100MG
  • 1G
  • ManufacturerSigma-Aldrich(India)
  • Product number390585
  • Product descriptionSuberohydroxamic acid 95%
  • Packaging1G
  • Price₹5130
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product number559418
  • Product descriptionSBHA - CAS 38937-66-5 - Calbiochem A cell-permeable bishydroxamic acid histone deacetylase (HDAC) inhibitor with anti-tumor properties.
  • Packaging100MG
  • Price₹15469.99
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) 390585 Suberohydroxamic acid 95% 1G ₹5130 2022-06-14 Buy
Sigma-Aldrich(India) 559418 SBHA - CAS 38937-66-5 - Calbiochem A cell-permeable bishydroxamic acid histone deacetylase (HDAC) inhibitor with anti-tumor properties. 100MG ₹15469.99 2022-06-14 Buy

Properties

Melting point :153-155 °C(lit.)
Density :1.219±0.06 g/cm3(Predicted)
storage temp. :−20°C
solubility :H2O: soluble
pka :9.18±0.20(Predicted)
form :lyophilized powder
color :White to Light Beige
Stability :Hygroscopic

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

Suberohydroxamic acid (SBHA) is a competitive histone deacetylase (HDAC) inhibitor that has been shown to inhibit HDAC1 (IC50 = 0.25 μM) and HDAC3 (IC50 = 0.30 μM). SBHA causes cell differentiation, cell cycle arrest, or apoptosis. HDAC inhibitors, including SBHA, act synergistically to kill cancer cells when used in combination with cytostatic drugs, allowing lower doses of both inhibitors and drugs to be used.

Related product price